Synovial Sarcoma, X Breakpoint 2 Interacting Protein (SSX2IP) Peptide
SSX2IP
Reactivity: Human
Host: Synthetic
BP, IHC, WB
-
- Target See all SSX2IP products
- SSX2IP (Synovial Sarcoma, X Breakpoint 2 Interacting Protein (SSX2IP))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-SSX2IP antibody (Catalog #: ARP53690_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- SSX2IP (Synovial Sarcoma, X Breakpoint 2 Interacting Protein (SSX2IP))
- Background
-
SSX2IP belongs to an adhesion system, which plays a role in the organization of homotypic, interneuronal and heterotypic cell-cell adherens junctions (AJs). It may connect the nectin-afadin and E-cadherin-catenin system through alpha-actinin and may be involved in organization of the actin cytoskeleton at AJs through afadin and alpha-actinin.
Alias Symbols: ADIP, FLJ10848, KIAA0923, MGC75026
Protein Interaction Partner: ACTN1,ACTN2,MLLT4,SSX2,SSX2IP,SSX3,ACTN1,MLLT4,USP11
Protein Size: 614 - Molecular Weight
- 68 kDa
- Gene ID
- 117178
- NCBI Accession
- NM_014021, NP_054740
- UniProt
- Q9Y2D8
-
You are here:
